Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
12.9M
-
Shares change
-
-232K
-
Total reported value, excl. options
-
$62.2M
-
Value change
-
-$3.16M
-
Put/Call ratio
-
58
-
Number of buys
-
17
-
Number of sells
-
-26
-
Price
-
$4.81
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q3 2014
53 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q3 2014.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.9M shares
of 71.9M outstanding shares and own 18.01% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT CO LLP (4.26M shares), ORBIMED ADVISORS LLC (2.82M shares), RENAISSANCE TECHNOLOGIES LLC (1.27M shares), Pine River Capital Management L.P. (1.1M shares), FIL Ltd (949K shares), BlackRock Fund Advisors (680K shares), Pictet Asset Management Ltd (267K shares), Invesco Ltd. (201K shares), MORGAN STANLEY (177K shares), and GOLDMAN SACHS GROUP INC (162K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.